Find a Tender
complete
Official procurement procedure
The supply of Blood Glucose & Ketone Monitoring Systems for Point of Care Testing
Blood analysers
Blood-testing reagents
Reagent strips
Published value
Not published
Submission deadline Not published
Lots published1
Procurement Executive Summary
AI & Search Synopsis
Generated from official OCDS record
Tenderline Synopsis: Royal United Hospitals Bath NHS Foundation Trust: "The supply of Blood Glucose & Ketone Monitoring Systems for Point of Care Testing". Published status: complete. Published value: Value not published. 1 published lot. Submission deadline not published. See the official notice for participation instructions.
| Contracting Authority | Royal United Hospitals Bath NHS Foundation Trust | Scope & Categories | Not published | Submission Window | complete No deadline published |
|---|---|---|---|---|---|
| Submission Gateway | Direct notice route | Legal Basis & Regime | Standard procurement | Estimated Value (exc. VAT) | Not published |
Bidder Intelligence · Authority Profile: Royal United Hospitals Bath NHS Foundation Trust
Market Analytics
Derived from OCDS awards & bid statistics
Published history for Royal United Hospitals Bath NHS Foundation Trust. These figures describe retained records, not a forecast of bids or a measure of buyer bias.
Published-to-award variance
Not availableInsufficient comparable data
Competition Density
1.5Bids / Report
Supplier ConcentrationNo estimate
Insufficient attributable awardsNo concentration estimate availablePayment Terms
Check noticePublished terms
Coverage: 8 active published awards; 2 bid reports (which may be per lot). Supplier values exclude multi-supplier awards, frameworks and DPS, and use GBP only. They are published award values, not payments. Published-to-award variance compares single-lot, single-award, single-supplier GBP procedures with explicitly non-framework/non-DPS status; increases remain in the average. Unpublished data stays unknown. Awarded suppliers are winners, not all bidders.
Procedure terms
Contracting AuthorityRoyal United Hospitals Bath NHS Foundation Trust | Procedure methodNot published | Procurement categoryNot published |
Statuscomplete | Framework / DPSNot published | CompetitionNot published |
Above thresholdNot published | Legal basisNot published | Tender period startsNot published |
Clarification deadlineNot published | Electronic submissionNot published | Submission languagesNot published |
Published3 Aug 2023, 08:56 BST | Last source update3 Aug 2023, 08:56 BST | Recurring procurementNot published |
ClassificationBlood analysers, Blood-testing reagents, Reagent strips | ||
Delivery area | ||
OCIDocds-h6vhtk-03ec9f | ||
What is being bought
A contract for the supply of Blood Glucose & Ketone Monitoring Systems for Point of Care Testing
What changed
From the official release history
- Status changed to complete
3 Aug 2023, 08:56 BST - Official notice release published
3 Aug 2023, 08:56 BST - Buyer information updated
3 Aug 2023, 08:56 BST
Lots and requirements (1)
Published by the contracting authority
- Lot 1 · #1Individual lot title not publishedStatus not publishedPublished valueNot publishedA contract for the supply of Blood Glucose & Ketone Monitoring Systems for Point of Care TestingContract periodNot publishedEligibilityNot publishedOptions / renewalNot published
Timeline
- Procedure published
3 Aug 2023, 08:56 BST - Award active
Not published · Not published - Contract active
Signed 26 Aug 2022, 00:00 BST · £241,000
Commercial outcome and competition
Awards Abbott Laboratories Limited Not published · Not published · active |
Contracts Contract £241,000 · signed 26 Aug 2022, 00:00 BST · active |
Bid statisticsNo aggregate bid statistics published |
Buyer and organisations in this procedure
Royal United Hospitals Bath NHS Foundation Trust
Contracting authority GB-FTS-81718Documents (0)
Official links; attachments are not copied
No linked documents are published
Related procedures (0)
No related procedures published
Planning and rationale
Planning budgetNot published |
No-engagement rationaleNot published |
Procedure rationaleRoyal United Hospitals Bath NHSFT (RUH) intends to award a contract under Regulation 32(2)(b)(ii), to Abbott Laboratories Limited, in respect of Blood Glucose Monitoring Systems for Point of Care Testing, for a period of twenty one months. This is to maintain continuation of service delivery and aligns the contract end date for this requirement to the same as North Bristol NHS Trust and University Hospitals Bristol and Weston NHS Foundation Trust, while a collaborative requirement is re-tendered as a South 3 collaborative contract, to ensure greater efficiency when procuring services. Abbott Laboratories Limited is the incumbent supplier and the new contract will ensure that the current service is maintained until the re-tender is complete, without risk to patient care or the accumulation of cost and resource pressures. To award another supplier a temporary arrangement of this nature may result in the following:<br/>Trust Turnaround Times and Patient Care: Variations in turnaround while new systems are set up and training of clinical staff is is undertaken. Currently procedures are established and consistent. Risking this could lead to increased Turnaround and delays to diagnosis, and in turn treatment, of patients within the Trust.<br/>IT and Report Transcription: The reporting and interpretation of results is an established process, and staff are familiar with the current processes. <br/>IT and Documentation: Changing provider will result in additional IT resource and system/document updates that will add to the department’s ongoing quality work.<br/>RUH has reviewed the factors described and considers that for the technical reasons listed, awarding Abbott Laboratories Limited is the only reasonable solution as it mitigates the risk of a detrimental effect on the service and the accumulation of preventable cost and resource pressures until the re-tender of the collaborative contract across the Trusts. RUH will observe a 10 day standstill from the date of this notice before entering into a contract with Abbott Laboratories Limited. |